X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with Pidilite Industries - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs PIDILITE INDUSTRIES - Comparison Results

PIDILITE INDUSTRIES 
   Change

Pidilite is present in consumer products and speciality industrial products.Consumer products with a 79% sales share include art materials, adhesives, sealants, fabric care and car care products. Industrial products consist of adhesives, pigments, le... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES PIDILITE INDUSTRIES AMAR REMEDIES/
PIDILITE INDUSTRIES
 
P/E (TTM) x -0.5 51.3 - View Chart
P/BV x 0.1 15.0 0.4% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 AMAR REMEDIES   PIDILITE INDUSTRIES
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
PIDILITE INDUSTRIES
Mar-16
AMAR REMEDIES/
PIDILITE INDUSTRIES
5-Yr Chart
Click to enlarge
High Rs164648 25.3%   
Low Rs86521 16.5%   
Sales per share (Unadj.) Rs261.6104.7 249.8%  
Earnings per share (Unadj.) Rs17.414.7 118.0%  
Cash flow per share (Unadj.) Rs22.317.3 128.6%  
Dividends per share (Unadj.) Rs03.65 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs100.754.3 185.6%  
Shares outstanding (eoy) m26.16512.68 5.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.55.6 8.6%   
Avg P/E ratio x7.239.7 18.1%  
P/CF ratio (eoy) x5.633.7 16.6%  
Price / Book Value ratio x1.210.8 11.5%  
Dividend payout %024.8 0.0%   
Avg Mkt Cap Rs m3,270299,585 1.1%   
No. of employees `000NA5.0 0.0%   
Total wages/salary Rs m1635,743 2.8%   
Avg. sales/employee Rs ThNM10,786.4-  
Avg. wages/employee Rs ThNM1,153.8-  
Avg. net profit/employee Rs ThNM1,517.8-  
INCOME DATA
Net Sales Rs m6,84453,695 12.7%  
Other income Rs m21510 4.1%   
Total revenues Rs m6,86554,204 12.7%   
Gross profit Rs m1,13111,739 9.6%  
Depreciation Rs m1281,331 9.6%   
Interest Rs m398133 299.9%   
Profit before tax Rs m62610,785 5.8%   
Minority Interest Rs m0-38 0.0%   
Prior Period Items Rs m029 0.0%   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m1213,221 3.8%   
Profit after tax Rs m4557,556 6.0%  
Gross profit margin %16.521.9 75.6%  
Effective tax rate %19.329.9 64.7%   
Net profit margin %6.614.1 47.2%  
BALANCE SHEET DATA
Current assets Rs m4,90421,482 22.8%   
Current liabilities Rs m3,5819,614 37.2%   
Net working cap to sales %19.322.1 87.5%  
Current ratio x1.42.2 61.3%  
Inventory Days Days12443 290.6%  
Debtors Days Days10050 202.0%  
Net fixed assets Rs m1,68915,075 11.2%   
Share capital Rs m262513 51.1%   
"Free" reserves Rs m2,35827,313 8.6%   
Net worth Rs m2,63527,829 9.5%   
Long term debt Rs m50794 541.7%   
Total assets Rs m6,86239,082 17.6%  
Interest coverage x2.682.3 3.1%   
Debt to equity ratio x0.20 5,720.7%  
Sales to assets ratio x1.01.4 72.6%   
Return on assets %12.419.7 63.2%  
Return on equity %17.327.1 63.6%  
Return on capital %31.039.1 79.3%  
Exports to sales %4.08.0 49.8%   
Imports to sales %010.7 0.0%   
Exports (fob) Rs m2734,302 6.3%   
Imports (cif) Rs mNA5,758 0.0%   
Fx inflow Rs m2734,336 6.3%   
Fx outflow Rs m26,680 0.0%   
Net fx Rs m271-2,343 -11.6%   
CASH FLOW
From Operations Rs m-3138,645 -3.6%  
From Investments Rs m-489-4,530 10.8%  
From Financial Activity Rs m769-3,563 -21.6%  
Net Cashflow Rs m-33552 -5.9%  

Share Holding

Indian Promoters % 25.5 69.5 36.7%  
Foreign collaborators % 0.0 0.6 -  
Indian inst/Mut Fund % 9.2 3.5 262.9%  
FIIs % 0.0 15.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 10.7 610.3%  
Shareholders   13,061 44,398 29.4%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   GILLETTE INDIA  K.S.OILS LTD  JYOTHY LABS  KARUTURI GLOBAL  RELAXO FOOTWEARS  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Trades Marginally Lower; IT Stocks Witness Losses(11:30 am)

Share markets in India are presently trading marginally lower. Sectoral indices are trading on a mixed note with stocks in the IT sector and power sector witnessing maximum selling pressure.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 5-YR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS